Factors Determining Inferior Survival Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma at a Referral Center in a Developing Country

This is a preview of subscription content, log in to check access.

References

  1. 1.

    McCarthy PL, Holstein SA, Petrucci MT et al (2017) Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol 35:3279

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Gonsalves WI, Buadi FK, Ailawadhi S, Bergsagel PL, Chanan Khan AA, Dingli D et al (2019) Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone Marrow Transplant 54(3):353–367

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Sonneveld P, Schmidt-Wolf IG, van der Holt B et al (2012) Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/GMMG-HD4 trial. J Clin Oncol 30:2946

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Kumar SK, Mikhael JR, Buadi FK et al (2009) Management of newly diagnosed symptomatic multiple myeloma: updated mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines. Mayo Clin Proc 84(12):1095–1110

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S et al (2013) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122–1128

    PubMed  PubMed Central  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Eucario Leon-Rodriguez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Waived due to the retrospective nature of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leon-Rodriguez, E., Rivera-Franco, M.M., Gomez-Vázquez, O.R. et al. Factors Determining Inferior Survival Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma at a Referral Center in a Developing Country. Indian J Hematol Blood Transfus 36, 582–584 (2020). https://doi.org/10.1007/s12288-020-01255-2

Download citation